Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results

The TuberOus SClerosis registry to increase disease Awareness (TOSCA) Post-Authorization Safety Study (PASS) was a non-interventional, multicenter, safety substudy that assessed the long-term safety of everolimus in patients with tuberous sclerosis complex (TSC) receiving everolimus for its licensed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Falcó Rojas, María Luz, Feucht, Martha, Macaya, Alfons, Wilken, Bernd, Hahn, Andreas, Maamari, Ricardo, Hirschberg, Yulia, Ridolfi, Antonia, Kingswood, John Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023743/
https://www.ncbi.nlm.nih.gov/pubmed/35462939
http://dx.doi.org/10.3389/fphar.2022.802334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023743/
https://www.ncbi.nlm.nih.gov/pubmed/35462939
http://dx.doi.org/10.3389/fphar.2022.802334

Ejemplares similares